This Article Full Text Full Text (PDF) All Versions of this Article: 1055-9965.EPI-08-0403v1 17/9/2458    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Moore, S. C. Articles by Leitzmann, M. F. Search for Related Content PubMed PubMed Citation Articles by Moore, S. C. Articles by Leitzmann, M. F. Related Collections Epidemiology Epidemiology: Classical Epidemiology

Physical Activity in Relation to Total, Advanced, and Fatal Prostate Cancer

¹ Divisions of Cancer Epidemiology and Genetics and ² Cancer Control and Prevention, National Cancer Institute, Bethesda, Maryland and ³ American Association of Retired Persons, Washington, District of Columbia

Requests for reprints: Steven C. Moore, Divisions of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Bethesda, MD 20892. Phone: 301-594-2415; Fax: 301-496-6829. E-mail: moorest{at}mail.nih.gov

Physical activity has been inconsistently related to total prostate cancer and few studies have examined whether this association varies by disease aggressiveness. We examined physical activity in relation to total, advanced, and fatal prostate cancer in the NIH-AARP Diet and Health Study. At baseline (1995-1996), 293,902 men ages 50 to 71 years completed a questionnaire inquiring about current frequency of vigorous exercise of at least 20 min of duration, as well as frequency of exercise during adolescence (ages 15-18). We used proportional hazards regression to calculate multivariate relative risks (RR) and 95% confidence intervals (95% CI). During up to 8.2 years of follow-up, 17,872 prostate cancer cases were identified, including 1,942 advanced and 513 fatal cases. Comparing frequent (5+ times per week) versus infrequent (less than once per week) vigorous exercise, exercise at baseline was not associated with risk of total prostate cancer (RR, 1.01; 95% CI, 0.96-1.07; P_trend = 0.78), advanced prostate cancer (RR, 1.14; 95% CI, 0.97-1.33; P_trend = 0.25), or fatal prostate cancer (RR, 0.90; 95% CI, 0.67-1.20; P_trend = 0.12). Increasing level of vigorous exercise during adolescence was associated with a small 3% reduction in total prostate cancer risk (frequent versus infrequent exercise during adolescence: RR, 0.97; 95% CI, 0.91-1.03; P_trend = 0.03) but was not associated with risk of advanced prostate cancer (RR, 0.95; 95% CI, 0.78-1.14; P_trend = 0.18) or fatal prostate cancer (RR, 0.96; 95% CI, 0.67-1.36; P_trend = 0.99). Neither vigorous exercise at baseline nor exercise during adolescence was related to risk of total, advanced, or fatal prostate cancer in this large prospective cohort. (Cancer Epidemiol Biomarkers Prev 2008;17(9):2458–66)